TVM Capital restructures; hires Schuler
TVM Capital has reorganised its life science investment practice. In the future, the firm will operate two dedicated teams with differentiated investment concepts to invest in pharmaceutical, biopharmaceutical, medical technologies (medtech) and healthcare services companies. The divisions will be called Healthcare Private Equity and Life Science Venture Capital.
The new Healthcare Private Equity team invests growth capital and provides buyout financing for growth-orientated small and medium-sized enterprises in the
pharmaceutical, diagnostic, medtech and healthcare services industries. The team is led by Christoph Schröder.
In addition, the firm has hired Bernie Schuler as senior advisor for the team. He focuses on sourcing, assessing, and structuring investments in European SMEs in the healthcare industry. Before joining TVM Capital, he was partner and head of healthcare at 3i buyouts in Frankfurt, where he built and led the dedicated European healthcare team.
The Life Science Venture team is headed by Hubert Birner and Alexandra Goll. Under their leadership, the TVM Life Science Venture team will continue to focus on a multi-stage venture capital investment approach spanning discovery and development stage companies with diversified product portfolios, technology platforms, single drug development projects as well as investments in market-ready products in the pharmaceutical and medtech markets.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds








